Yes, you read that right, bleeding risk could land you in the thick of it
Commonly endorsed domains were clinical signs (100% of studies), QoL (94.7%), symptoms (73.7%), and adverse events (68.4%).)
See how RYBELSUS measured up vs multiple treatments for type 2 diabetes in the PIONEER phase 3 clinical trial program Bring A1C down with the proven efficacy of RYBELSUS 26-WEEK RESULTS Superior A1C reduction vs Jardiance (empagliflozin) 1 Superior A1C control vs Jardiance 1,2* PIONEER 2 study design 1,2 In an open-label trial with a primary endpoint of mean change in A1C from baseline to 26 weeks, 822 adult patients with type 2 diabetes on metformin were randomized to RYBELSUS 14 mg (n=411) or Jardiance 25 mg (n=410), both once daily
Thyrocyte-derived exosome-targeted dendritic cells stimulate strong CD4+ T lymphocyte responses
In: Caballero B, Allen L, Prentice A, editors
Learn More Now: The Body Insight Method